GSK's RSV vaccine shows long-term efficacy in late-stage trial https://ift.tt/GOx0fYK

Phase III' trial showed vaccine efficacy against RSV-lower respiratory tract disease and severe disease over two full RSV seasons, including in participants with underlying medical conditions.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/wcspOkE